James Chalmers, MBChB, PhD, discusses the ASPEN trial's findings on brensocatib's impact on lung structure and function in bronchiectasis patients.
James Chalmers, MBChB, PhD
Advertisement
Articles by James Chalmers, MBChB, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
KEYNOTE-755 Confirms Broad Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer
3
From Stigma to Breakthrough: Psychedelic Medicine
4
OTC Case Studies: Dry Eye
5
